UVACO, the direct-selling biotechnology brand under Taiwan’s leading biotechnology enterprise, Grape King Group, has officially entered the Southeast Asian market with the successful establishment of its Kuala Lumpur operations centre in Malaysia. The move marks an important new milestone in UVACO’s international expansion beyond Taiwan and strengthens its presence in the Southeast Asian market.

The Malaysia launch event brought together the brand’s leadership team, business partners and members of the business community. UVACO Global Chief Executive Officer Tseng Mei-Ching also led her team at the event, engaging with Malaysian market partners and sharing the brand’s future development direction and plans for the local market.

As a biotechnology brand under Grape King Group, UVACO is introducing several of its popular products to Malaysia, including Antrodia cinnamomea-related products, meal replacement products and Xin Yue Kang. Leveraging Taiwan’s accumulated expertise in health supplements, biotechnology research and development, and product innovation, UVACO aims to further tap into Malaysia’s steadily growing health and wellness consumer market.

Malaysia has a multicultural population, a mature business environment and a strategic position as a gateway to the wider ASEAN market. As consumers become increasingly health-conscious, demand for health management, nutritional supplementation and health supplements continues to gain attention, positioning Malaysia as one of the important markets for Asian health and wellness brands seeking overseas expansion.

The establishment of UVACO’s Kuala Lumpur operations centre provides the brand with a physical presence in Malaysia while laying a solid foundation for future market development, product experiences, partner training and business expansion.

According to information shared at the event, UVACO will also organise a large-scale market presentation in Kuala Lumpur as part of its next phase of development, providing the Malaysian market with a deeper understanding of the brand’s philosophy, product offerings and business development model.

From Taiwan to Malaysia, UVACO’s latest expansion also reflects the growing ambition of Taiwan’s health and biotechnology sector to extend its international footprint. Moving forward, attention will be on how UVACO translates its years of accumulated product strengths, brand experience and business model into sustainable growth in Southeast Asia, while leveraging Malaysia as a strategic base for further regional expansion.